Definitive Contract HHSD200200932590C
Award Date
9/21/09
Potential Completion Date
9/17/19
Potential Value
$4.4M
Federal Agency
CDC Office of Acquisition Services
Awardee
Rutgers, The State University
Ultimate Awardee
Rutgers, The State University
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
20
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $300,000.00 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Rutgers, The State University of New Jersey, doing business as RBHS-New Jersey Medical School, for multidrug resistance research. The contract has a completion date of September 29, 2018 and was not set aside for any specific business category. Rutgers is a non-profit organization, 1862 land grant college, and educational institution that has previously provided medical...
This is a $191,904 cost-reimbursement contract awarded by the Centers for Disease Control and Prevention (CDC) to Rutgers, The State University of New Jersey. The contract, titled "UNLOCKING ECOLOGY OF ARB," has a period of performance from September 16, 2016 to March 31, 2018. Rutgers, as a major public research institution, has extensive experience conducting research and development for federal agencies such as the Department of Defense, NASA, and the Department of Health and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,434,867.00 definitive cost-no-fee contract to The Johns Hopkins University to support the Tuberculosis Trials Consortium (TBTC). This contract, which does not have a set-aside designation, was awarded on September 18, 2019 and has a completion date of March 17, 2021. The Johns Hopkins University, a private non-profit research university, will provide clinical trial and data coordination services...
The Centers for Disease Control and Prevention (CDC) awarded a $9,856,205.74 definitive contract to The Medical University of South Carolina (MUSC) for tuberculosis clinical trials and research support. The contract runs from January 1, 2021 to December 31, 2030 and does not have a set-aside designation. The University of Cape Town in South Africa is a major subcontractor, providing pharmacokinetics research support for the trials. This contract is part of the CDC's Tuberculosis Trials...
Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to The Trustees of Columbia University in the City of New York Sponsored Projects Administration Division (Columbia University) for the TUBERCULOSIS TRIALS CONSORTIUM (TBTC) project. The contract has a potential value of $523,857.39 and is a Cost No Fee type contract. The contract does not have a set-aside designation and was awarded on September 18, 2019 with a completion date of...
This federal contract award is for the World Trade Center Health Program Clinical Center of Excellence Services, provided by Rutgers, The State University of New Jersey, doing business as Cancer Institute of New Jersey. The $18,052,989.55 contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention on April 1, 2017 and is set to be completed by September 30, 2022. The contract is a definitive, cost-plus-fixed-fee award with no set-aside...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Rutgers, The State University of New Jersey, doing business as Cancer Institute of New Jersey. The contract has a potential value of $11,814.00 and will provide tuition and research credits. There is no set-aside designation for this contract. Rutgers is a non-profit, educational institution and 1862 Land Grant...
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, with a ceiling value of $15,729,937.34. The contract is for tuberculosis trials and consortium services over a 10-year period of performance from January 1, 2021 to December 31, 2030. There is no set-aside designation for this award. The contract requires the vendor to...